Developer docs
API playgroundTry for free, no card

Search company profiles

GeneProof

Full company profile

uuid0008z7e

Namestring
GeneProof
Legal namestring
GeneProof a.s.
Websiteurl
geneproof.com
Company typeenum
Private
Founded yearint
2005
Descriptiontext

GeneProof a.s. is a privately held Czech molecular diagnostics company founded in 2005 in Brno by Radek Horváth and Miloš Dendis, scientists who introduced PCR methodology into routine Czech clinical practice. The company designs, manufactures, and sells a portfolio of more than 75 CE IVD certified real-time PCR diagnostic kits, nucleic acid extraction kits, and laboratory instruments across seven diagnostic categories: bloodborne infections, immunocompromised/transplant, sexually transmitted infections, neuroinfections, respiratory infections, antibiotic resistance, and thrombotic mutations. Its flagship myCROBE Fully Automated Solution is a sample-to-result instrument handling 1-36 samples per run with up to 8 multiplexed PCR tests per sample, complemented by croBEE extraction systems and the newly launched croGENE Real-Time PCR System.

GeneProof generates revenue through B2B sales of PCR kits (recurring consumable, one-time per test purchase), extraction kits and accessories, and capital instruments, all sold exclusively via a quote-based model through regional sales managers and a global distributor network of more than 50 partners covering 75+ countries. Approximately 90% of production is exported, with end customers being clinical laboratories, hospitals, public health authorities, and university medical centers. The company achieved EU IVDR Quality Management System certification in January 2023, holds ISO 13485:2016 certification, and merged with American Laboratory Products Company (ALPCO) in 2022 under the NuvinkaDx parent, with Erik M. Allen appointed CEO in April 2023. Distribution was further expanded through a 2023 strategic partnership with Thermo Fisher Scientific for the TaqPath Menu | GeneProof PCR tests.

The business operates approximately 100 employees out of its Brno headquarters, with named regional business managers covering APAC/Africa/CIS, Eastern Europe/Middle East, LATAM/Iberia, Western Europe, and Czech/Slovak markets. GeneProof emphasizes expert technical support with guaranteed 24-hour business-day response, GLP training programs held twice yearly, and broad instrument compatibility (validated on Applied Biosystems, Bio-Rad CFX, Roche LightCycler, Qiagen Rotor-Gene, and others) as a core differentiation against closed-cartridge competitors. Recent strategic moves include the croGENE launch (September 2025), RT-PCR Respiratory Panel 1 with DIANA Biotechnologies (December 2025), and a planned CMV IVDR launch on myCROBE (April 2026).

Short descriptiontext

GeneProof is a Czech molecular diagnostics company founded in 2005 that designs, manufactures, and sells CE IVD certified real-time PCR kits, extraction systems, and the myCROBE automated platform for clinical laboratories in more than 75 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersBrno, Czechia
HQ citystring
Brno
HQ countrystring
Czechia
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
molecular diagnostics kits, PCR diagnostic reagents, automated PCR systems, clinical microbiology diagnostics, nucleic acid extraction
Industry4 codes
PRIMARYHLAHAAAD
Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAAALAA
Molecular Diagnostics (PCR/qPCR, NGS-based assays)
NAICS code2 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Medical Equipment and Supplies Manufacturing3391
SIC code3 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Surgical & Medical Instruments & Apparatus3841
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Molecular In Vitro Diagnostics
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1PCR Diagnostic Kits
TypeOne Time License
Description

GeneProof manufactures and sells a wide portfolio of CE IVD certified PCR kits across 7 diagnostic categories: Bloodborne Infections, Immunocompromised/Transplant, Sexually Transmitted Infections, Neuroinfections, Respiratory Infections, Antibiotic Resistance, and Thrombotic Mutations. Kits are sold as one-time purchases (unit pricing per test), with ready-to-use format requiring no reagent preparation. Over 75 products distributed to more than 75 countries.

geneproof.com
2Nucleic Acid Extraction Kits and Accessories
TypeOne Time License
Description

Extraction kits (croBEE 101A Whole Blood DNA Extraction Kit, croBEE 201A Nucleic Acid Extraction Kit, PathogenFree DNA/RNA Isolation Kits, myCROBE/croBEE 2.0 Universal Extraction Kit) and accessories (pretreatment tubes, tips, PCR plates, seals, waste bins). Sold alongside PCR kits as consumable recurring purchases.

geneproof.com
3Laboratory Instruments
TypeHardware Sales
Description

Sale of laboratory equipment including myCROBE fully automated instrument, croBEE 2.0 Nucleic Acid Extraction System, croBEE NA16 Nucleic Acid Extraction System Plus, croBEE Real-Time PCR System, and croGENE Real-Time PCR System. Instruments sold alongside third-party equipment from Biosan and Alpina (bioreactors, laminar flow cabinets).

geneproof.com
4Distribution of Third-Party Products
TypeOne Time License
Description

GeneProof acts as a distributor for the RT-PCR Respiratory Panel 1 from DIANA Biotechnologies, enabling laboratories to access a multiplex respiratory panel (Influenza A/B, RSV, SARS-CoV-2) through GeneProof's distribution network.

geneproof.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Others
Pricing details1 tier
1B2B direct sales and distributor channel - pricing by quote
ModelOtherBilling cadencePay-as-you-go
Notes

GeneProof operates exclusively through B2B sales channels. No public pricing is available on the website. Customers must contact the sales department for quotes. Instruments (myCROBE, croBEE systems) and consumables (PCR kits, extraction kits) are sold via direct sales team and global distributor network.

geneproof.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1myCROBE®
Description

Fully automated sample-to-result solution for molecular diagnostics.

geneproof.com
+3 more records
Core offering1 text field

GeneProof develops, manufactures, and sells real-time PCR-based molecular in vitro diagnostic kits and instruments for clinical laboratories, hospitals, and public-health institutions. Its offerings span more than 75 CE IVD-certified PCR kits across seven disease categories (bloodborne infections, immunocompromised/transplant, sexually transmitted infections, neuroinfections, respiratory infections, antibiotic resistance, and thrombotic mutations), the myCROBE fully automated sample-to-result instrument, croBEE and croGENE real-time PCR systems, nucleic acid extraction systems, and consumables — sold through a global distributor network and direct sales teams in over 75 countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Up to 108 samples and 270 tests/day processing capacity on myCROBE automated system
+4 more records
Product overview1 text field

GeneProof is a molecular in vitro diagnostics company offering a comprehensive portfolio of PCR-based diagnostic products. The portfolio consists of three integrated pillars: (1) the myCROBE Fully Automated Solution - a sample-to-result automated system comprising the myCROBE instrument with dedicated IT PCR Kits (CMV, EBV, BKV, JCV, HSV, HHV-6/7, HHV-8, VZV), STI PCR Kits (CT, NG, MG, MH, UU, UP, TV, GV), and Thrombotic PCR Kits (FII, FV, FXIII, MTHFR, PAI-1); (2) Manual PCR kits organized by disease category including Bloodborne Infections (HBV, HCV, HIV-1), Immunocompromised/Transplant (CMV, EBV, BKV, JCV, HSV, HHV, VZV, Parvovirus B19), Sexually Transmitted Infections (CT, NG, MG, MH, UU, UP, TV, GV, TP, HPV), Respiratory Infections (Respiratory Panel 1, Flu, SARS-CoV-2, Bordetella, Chlamydia pneumoniae, Legionella, Mycoplasma, TB), Neuroinfections (Borrelia, BK/JC, HSV, VZV), Thrombotic Mutations (FII, FV, FXIII, MTHFR, PAI-1), and Antibiotic Resistance (VRE); and (3) Extraction systems including croBEE 2.0 and NA16 Nucleic Acid Extraction Systems, croBEE and croGENE Real-Time PCR Instruments, and associated extraction and control kits. All products are CE IVD certified with IVDR compliance. GeneProof was founded in 2005 in Czech Republic and merged with ALPCO in 2022.

Product and service14 records
1myCROBE Fully Automated Solution
CategoryAutomated Molecular Diagnostic Instrument
Description

Fully automated sample-to-result molecular diagnostic instrument that processes 1-36 samples per run with up to 96 tests per run, integrating nucleic acid extraction, PCR setup and automated analysis using magnetic particle-based extraction and bidirectional LIS connectivity via HL7 and ASTM protocols. Designed for clinical microbiology and genetics laboratories.

2croBEE 2.0 Nucleic Acid Extraction System
CategoryNucleic Acid Extraction Instrument
Description

Automated high-throughput nucleic acid extraction system for clinical laboratories, CE IVD and IVDR certified, supporting manual or automated DNA/RNA isolation across a range of biological specimen types.

3croBEE NA16 Nucleic Acid Extraction System Plus
CategoryNucleic Acid Extraction Instrument
Description

Automated nucleic acid extraction instrument designed for DNA/RNA isolation from a variety of clinical sample types. IVDR certified.

4croBEE Real-Time PCR System
CategoryReal-Time PCR Instrument
Description

Real-time PCR instrument for clinical molecular diagnostics, IVDR certified, designed for use with GeneProof PCR kits and validated for open-platform workflows.

5croGENE Real-Time PCR System
CategoryReal-Time PCR Instrument
Description

High-performance open-platform real-time PCR instrument launched in 2025 for rapid and reliable molecular diagnostics in clinical laboratories, compatible with GeneProof PCR kits and validated for open workflow use.

6RT-PCR Respiratory Panel 1
CategoryMultiplex Respiratory PCR Kit
Description

Multiplex RT-PCR kit for simultaneous detection of Influenza A, Influenza B, RSV, and SARS-CoV-2 in a single sample. Developed by DIANA Biotechnologies and distributed globally by GeneProof. CE IVD certified under IVDD.

7myCROBE IT Panel
CategoryAutomated Immunocompromised/Transplant PCR Kit Panel
Description

Automated myCROBE PCR kit panel for immunocompromised and transplant care diagnostics, detecting CMV, EBV, BKV, JCV, HSV-1/2, HHV-6/7, HHV-8, and VZV with random-access, à la carte multiplexing on the myCROBE instrument.

8GeneProof Hepatitis B Virus (HBV) PCR Kit
CategoryBloodborne Infection PCR Kit
Description

CE IVD real-time PCR kit for qualitative and quantitative detection of Hepatitis B Virus (HBV) DNA in clinical samples, for professional use in clinical laboratory settings.

9GeneProof Hepatitis C Virus (HCV) Diagnostic PCR Kit
CategoryBloodborne Infection PCR Kit
Description

CE IVD real-time PCR kit for detection of Hepatitis C Virus (HCV) RNA in clinical samples, for professional use in clinical laboratory settings.

10GeneProof HIV type 1 (HIV-1) Diagnostic PCR Kit
CategoryBloodborne Infection PCR Kit
Description

CE IVD real-time PCR kit for detection of HIV type 1 (HIV-1) RNA in clinical samples, for professional use in clinical laboratory settings.

11GeneProof Bordetella pertussis/parapertussis PCR Kit
CategoryRespiratory Infection PCR Kit
Description

CE IVD real-time PCR kit for detection and differential diagnosis of Bordetella pertussis and Bordetella parapertussis, validated on multiple real-time PCR cyclers including Applied Biosystems, BioRad CFX, Roche LightCycler, Qiagen Rotor-Gene, Agilent AriaMx, QuantStudio, BioQuant-96, and QuantGene 9600.

12GeneProof VRE PCR Kit
CategoryAntibiotic Resistance PCR Kit
Description

CE IVD real-time PCR kit for detection of Vancomycin-Resistant Enterococci (VRE) in clinical samples, for antibiotic resistance surveillance in clinical microbiology laboratories.

13croBEE 101A Whole Blood DNA Extraction Kit
CategoryWhole Blood DNA Extraction Kit
Description

Whole blood DNA extraction kit designed for genomic DNA isolation from whole-blood samples, used with croBEE extraction systems for clinical molecular workflows.

14Good Laboratory Practice (GLP) Training Course
CategoryProfessional Training Service
Description

Twice-yearly training program held in spring and autumn covering theoretical and practical aspects of molecular biology laboratory procedures using GeneProof products, delivered to laboratory personnel.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2025-12-16
Description

GeneProof entered a collaboration with DIANA Biotechnologies to distribute the RT-PCR Respiratory Panel 1, a multiplex test detecting Influenza A, Influenza B, RSV, and SARS-CoV-2 from a single sample. GeneProof acts as the distributor for this CE IVDD product, offering it through its global distribution network. The partnership leverages DIANA's expertise in innovative PCR products and GeneProof's established distribution channels.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-04-17
Description

ALPCO-GeneProof and Thermo Fisher Scientific announced a strategic partnership in April 2023 to bring the TaqPath Menu | GeneProof PCR tests to market. This partnership leverages Thermo Fisher's global distribution reach for molecular diagnostics products, expanding GeneProof's market access significantly through Thermo Fisher's established commercial channels.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

In 2022, GeneProof merged with American Laboratory Products Company (ALPCO), a specialized in vitro diagnostics company based in Salem, USA. The merger created a global market leader in diagnostic products with broad capabilities including new immunoassay test kits, RT PCR testing products, and automated laboratory instrument solutions. ALPCO distributes GeneProof products in North America. GeneProof's parent company post-merger is NuvinkaDx.

Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2021-01-01
Description

GeneProof partnered with Biosan (European manufacturer of laboratory instruments) beginning in 2021 to offer complementary laboratory equipment including RTS-1C and RTS-8 bioreactors based on Reverse-Spin technology. Biosan focuses on innovations in molecular biology, biochemistry, immunology, and cell biology with over 30 years of R&D tradition.

Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2021-01-01
Description

GeneProof partnered with Alpina (largest laminar flow cabinet manufacturer in Central Europe) beginning in 2021 to offer complementary laboratory equipment. Alpina manufactures over 20 models of laminar flow and biosafety cabinets certified to EN 12469, combining modern technology, highest quality materials, and precise manufacturing.

Strategic tierMinorTypeOthers
Description

GeneProof uses Google Analytics and Google AdWords for website analytics and digital advertising, with a Data Processing Amendment in place per GDPR requirements.

Strategic tierMinorTypeOthers
Description

GeneProof uses Mailchimp for email marketing and commercial communications, with a Privacy Policy agreement in place per GDPR requirements.

8Facebook
Strategic tierMinorTypeOthers
Description

GeneProof maintains a Facebook company page and uses Facebook's data processing services with a Data Policy agreement in place per GDPR requirements.

geneproof.com
Strategic tierMinorTypeOthers
Description

GeneProof maintains a LinkedIn company page with a Data Processing Agreement in place per GDPR requirements.

Strategic tierMinorTypeOthers
Description

ViaAurea provides web hosting and digital services for the GeneProof website (www.geneproof.com), with a Privacy Policy agreement in place per GDPR requirements.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

TIB Molbiol (now owned by Roche) is one of the closest direct competitors to GeneProof in PCR-based molecular diagnostic kits for infectious diseases, including respiratory pathogens, HSV, CMV, and a similar ready-to-use master mix design philosophy. Competes head-to-head with GeneProof in the European clinical lab segment.

2Seegene
TypeDirect peer
Description

Seegene is a Korean molecular diagnostics company specializing in multiplex PCR reagents for syndromic testing (respiratory, STI, gastrointestinal). Its high-multiplex technology and broad assay menu directly overlap with GeneProof's STI and respiratory infection product lines.

TypeDirect peer
Description

Fast Track Diagnostics, now part of Siemens Healthineers, develops real-time PCR kits for infectious disease and genetic testing with a portfolio and customer base closely aligned to GeneProof's. Both companies target mid-sized clinical laboratories with multiplex and single-plex kits.

TypeDirect peer
Description

ELITech Group is a European molecular diagnostics company offering PCR kits, instruments, and extraction systems for infectious disease and genetic testing. Its product range and mid-market positioning directly overlap with GeneProof's portfolio and customer base.

TypeBroad incumbent
Description

DiaSorin is a global diagnostics major with a molecular diagnostics franchise (including the Liaison MDX line acquired from Luminex). As a broader incumbent, it competes in the same IVD infectious disease and transplant testing space as GeneProof, but at much larger scale and with a wider product portfolio.

TypeBroad incumbent
Description

Cepheid, owned by Danaher, sells the GeneXpert closed-cartridge molecular diagnostic system used widely in clinical labs and hospital point-of-care settings. It is a broader incumbent that competes with GeneProof's myCROBE sample-to-result system and PCR kits across infectious disease testing.

TypeBroad incumbent
Description

bioMérieux's BioFire FilmArray syndromic panels compete directly with GeneProof's respiratory and STI panels. As a global diagnostics major, bioMérieux offers fully integrated closed-system molecular diagnostics to the same clinical lab customers GeneProof serves.

TypeBroad incumbent
Description

QIAGEN is a major life sciences and molecular diagnostics company whose PCR kits, extraction systems, and QIAstat-Dx platform overlap with GeneProof's product range. Its Rotor-Gene Q and broader instrument portfolio place it in adjacent competition across multiple of GeneProof's disease categories.

TypeBroad incumbent
Description

Hologic's Panther molecular diagnostics system and Aptima assays serve the same clinical lab and hospital market as GeneProof, particularly in STI and women's health screening. As a broad incumbent with global reach, it competes for the same accounts.

TypeEmerging player
Description

Promega supplies nucleic acid extraction chemistries and molecular biology reagents used in clinical and research labs, with emerging clinical diagnostics offerings. While primarily a tools/reagents supplier, it overlaps with GeneProof's extraction and amplification reagent categories and competes for the same laboratory customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers14 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment8 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration8 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

GeneProof

Molecular In Vitro Diagnosticsgeneproof.com

GeneProof is a Czech molecular diagnostics company founded in 2005 that designs, manufactures, and sells CE IVD certified real-time PCR kits, extraction systems, and the myCROBE automated platform for clinical laboratories in more than 75 countries.

What GeneProof does

GeneProof a.s. is a privately held Czech molecular diagnostics company founded in 2005 in Brno by Radek Horváth and Miloš Dendis, scientists who introduced PCR methodology into routine Czech clinical practice. The company designs, manufactures, and sells a portfolio of more than 75 CE IVD certified real-time PCR diagnostic kits, nucleic acid extraction kits, and laboratory instruments across seven diagnostic categories: bloodborne infections, immunocompromised/transplant, sexually transmitted infections, neuroinfections, respiratory infections, antibiotic resistance, and thrombotic mutations. Its flagship myCROBE Fully Automated Solution is a sample-to-result instrument handling 1-36 samples per run with up to 8 multiplexed PCR tests per sample, complemented by croBEE extraction systems and the newly launched croGENE Real-Time PCR System.

GeneProof generates revenue through B2B sales of PCR kits (recurring consumable, one-time per test purchase), extraction kits and accessories, and capital instruments, all sold exclusively via a quote-based model through regional sales managers and a global distributor network of more than 50 partners covering 75+ countries. Approximately 90% of production is exported, with end customers being clinical laboratories, hospitals, public health authorities, and university medical centers. The company achieved EU IVDR Quality Management System certification in January 2023, holds ISO 13485:2016 certification, and merged with American Laboratory Products Company (ALPCO) in 2022 under the NuvinkaDx parent, with Erik M. Allen appointed CEO in April 2023. Distribution was further expanded through a 2023 strategic partnership with Thermo Fisher Scientific for the TaqPath Menu | GeneProof PCR tests.

The business operates approximately 100 employees out of its Brno headquarters, with named regional business managers covering APAC/Africa/CIS, Eastern Europe/Middle East, LATAM/Iberia, Western Europe, and Czech/Slovak markets. GeneProof emphasizes expert technical support with guaranteed 24-hour business-day response, GLP training programs held twice yearly, and broad instrument compatibility (validated on Applied Biosystems, Bio-Rad CFX, Roche LightCycler, Qiagen Rotor-Gene, and others) as a core differentiation against closed-cartridge competitors. Recent strategic moves include the croGENE launch (September 2025), RT-PCR Respiratory Panel 1 with DIANA Biotechnologies (December 2025), and a planned CMV IVDR launch on myCROBE (April 2026).

GeneProof firmographics

Firmographics
Name
GeneProof
Legal name
GeneProof a.s.
Website
https://geneproof.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
51–100 employees
Short description
GeneProof is a Czech molecular diagnostics company founded in 2005 that designs, manufactures, and sells CE IVD certified real-time PCR kits, extraction systems, and the myCROBE automated platform for clinical laboratories in more than 75 countries.
Ownership category
akta.pro rank

GeneProof industry classification

Industry
Product category
Molecular In Vitro Diagnostics
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Medical Equipment and Supplies Manufacturing (3391)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro industry
PRIMARYHLAHAAAD
Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAAALAA
Molecular Diagnostics (PCR/qPCR, NGS-based assays)

Keywords

  • Molecular diagnostics kits
  • PCR diagnostic reagents
  • Automated PCR systems
  • Clinical microbiology diagnostics
  • Nucleic acid extraction

Where GeneProof is headquartered

Location

Headquarters

HQ city
Brno
HQ country
Czechia
HQ region
Europe

Offices1 record

Markets served

GeneProof business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Others

Revenue model

  1. PCR Diagnostic Kits: GeneProof manufactures and sells a wide portfolio of CE IVD certified PCR kits across 7 diagnostic categories: Bloodborne Infections, Immunocompromised/Transplant, Sexually Transmitted Infections, Neuroinfections, Respiratory Infections, Antibiotic Resistance, and Thrombotic Mutations. Kits are sold as one-time purchases (unit pricing per test), with ready-to-use format requiring no reagent preparation. Over 75 products distributed to more than 75 countries.
  2. Nucleic Acid Extraction Kits and Accessories: Extraction kits (croBEE 101A Whole Blood DNA Extraction Kit, croBEE 201A Nucleic Acid Extraction Kit, PathogenFree DNA/RNA Isolation Kits, myCROBE/croBEE 2.0 Universal Extraction Kit) and accessories (pretreatment tubes, tips, PCR plates, seals, waste bins). Sold alongside PCR kits as consumable recurring purchases.
  3. Laboratory Instruments: Sale of laboratory equipment including myCROBE fully automated instrument, croBEE 2.0 Nucleic Acid Extraction System, croBEE NA16 Nucleic Acid Extraction System Plus, croBEE Real-Time PCR System, and croGENE Real-Time PCR System. Instruments sold alongside third-party equipment from Biosan and Alpina (bioreactors, laminar flow cabinets).
  4. Distribution of Third-Party Products: GeneProof acts as a distributor for the RT-PCR Respiratory Panel 1 from DIANA Biotechnologies, enabling laboratories to access a multiplex respiratory panel (Influenza A/B, RSV, SARS-CoV-2) through GeneProof's distribution network.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goB2B direct sales and distributor channel - pricing by quote

Go-to-market motion3 records

Distribution channels5 records

Marketing channels9 records

GeneProof product offering

Product offering

Core offering

GeneProof develops, manufactures, and sells real-time PCR-based molecular in vitro diagnostic kits and instruments for clinical laboratories, hospitals, and public-health institutions. Its offerings span more than 75 CE IVD-certified PCR kits across seven disease categories (bloodborne infections, immunocompromised/transplant, sexually transmitted infections, neuroinfections, respiratory infections, antibiotic resistance, and thrombotic mutations), the myCROBE fully automated sample-to-result instrument, croBEE and croGENE real-time PCR systems, nucleic acid extraction systems, and consumables — sold through a global distributor network and direct sales teams in over 75 countries.

Product overview

GeneProof is a molecular in vitro diagnostics company offering a comprehensive portfolio of PCR-based diagnostic products. The portfolio consists of three integrated pillars: (1) the myCROBE Fully Automated Solution - a sample-to-result automated system comprising the myCROBE instrument with dedicated IT PCR Kits (CMV, EBV, BKV, JCV, HSV, HHV-6/7, HHV-8, VZV), STI PCR Kits (CT, NG, MG, MH, UU, UP, TV, GV), and Thrombotic PCR Kits (FII, FV, FXIII, MTHFR, PAI-1); (2) Manual PCR kits organized by disease category including Bloodborne Infections (HBV, HCV, HIV-1), Immunocompromised/Transplant (CMV, EBV, BKV, JCV, HSV, HHV, VZV, Parvovirus B19), Sexually Transmitted Infections (CT, NG, MG, MH, UU, UP, TV, GV, TP, HPV), Respiratory Infections (Respiratory Panel 1, Flu, SARS-CoV-2, Bordetella, Chlamydia pneumoniae, Legionella, Mycoplasma, TB), Neuroinfections (Borrelia, BK/JC, HSV, VZV), Thrombotic Mutations (FII, FV, FXIII, MTHFR, PAI-1), and Antibiotic Resistance (VRE); and (3) Extraction systems including croBEE 2.0 and NA16 Nucleic Acid Extraction Systems, croBEE and croGENE Real-Time PCR Instruments, and associated extraction and control kits. All products are CE IVD certified with IVDR compliance. GeneProof was founded in 2005 in Czech Republic and merged with ALPCO in 2022.

Differentiator

Problem solved

Functional benefit

Brands

  • myCROBE®: Fully automated sample-to-result solution for molecular diagnostics.
  • croBEE®
  • croGENE®
  • PathogenFree®

Products and services

  • myCROBE Fully Automated Solution Fully automated sample-to-result molecular diagnostic instrument that processes 1-36 samples per run with up to 96 tests per run, integrating nucleic acid extraction, PCR setup and automated analysis using magnetic particle-based extraction and bidirectional LIS connectivity via HL7 and ASTM protocols. Designed for clinical microbiology and genetics laboratories.
  • croBEE 2.0 Nucleic Acid Extraction System Automated high-throughput nucleic acid extraction system for clinical laboratories, CE IVD and IVDR certified, supporting manual or automated DNA/RNA isolation across a range of biological specimen types.
  • croBEE NA16 Nucleic Acid Extraction System Plus Automated nucleic acid extraction instrument designed for DNA/RNA isolation from a variety of clinical sample types. IVDR certified.
  • croBEE Real-Time PCR System Real-time PCR instrument for clinical molecular diagnostics, IVDR certified, designed for use with GeneProof PCR kits and validated for open-platform workflows.
  • croGENE Real-Time PCR System High-performance open-platform real-time PCR instrument launched in 2025 for rapid and reliable molecular diagnostics in clinical laboratories, compatible with GeneProof PCR kits and validated for open workflow use.
  • RT-PCR Respiratory Panel 1 Multiplex RT-PCR kit for simultaneous detection of Influenza A, Influenza B, RSV, and SARS-CoV-2 in a single sample. Developed by DIANA Biotechnologies and distributed globally by GeneProof. CE IVD certified under IVDD.
  • myCROBE IT Panel Automated myCROBE PCR kit panel for immunocompromised and transplant care diagnostics, detecting CMV, EBV, BKV, JCV, HSV-1/2, HHV-6/7, HHV-8, and VZV with random-access, à la carte multiplexing on the myCROBE instrument.
  • GeneProof Hepatitis B Virus (HBV) PCR Kit CE IVD real-time PCR kit for qualitative and quantitative detection of Hepatitis B Virus (HBV) DNA in clinical samples, for professional use in clinical laboratory settings.
  • GeneProof Hepatitis C Virus (HCV) Diagnostic PCR Kit CE IVD real-time PCR kit for detection of Hepatitis C Virus (HCV) RNA in clinical samples, for professional use in clinical laboratory settings.
  • GeneProof HIV type 1 (HIV-1) Diagnostic PCR Kit CE IVD real-time PCR kit for detection of HIV type 1 (HIV-1) RNA in clinical samples, for professional use in clinical laboratory settings.
  • GeneProof Bordetella pertussis/parapertussis PCR Kit CE IVD real-time PCR kit for detection and differential diagnosis of Bordetella pertussis and Bordetella parapertussis, validated on multiple real-time PCR cyclers including Applied Biosystems, BioRad CFX, Roche LightCycler, Qiagen Rotor-Gene, Agilent AriaMx, QuantStudio, BioQuant-96, and QuantGene 9600.
  • GeneProof VRE PCR Kit CE IVD real-time PCR kit for detection of Vancomycin-Resistant Enterococci (VRE) in clinical samples, for antibiotic resistance surveillance in clinical microbiology laboratories.
  • croBEE 101A Whole Blood DNA Extraction Kit Whole blood DNA extraction kit designed for genomic DNA isolation from whole-blood samples, used with croBEE extraction systems for clinical molecular workflows.
  • Good Laboratory Practice (GLP) Training Course Twice-yearly training program held in spring and autumn covering theoretical and practical aspects of molecular biology laboratory procedures using GeneProof products, delivered to laboratory personnel.

Quantifiable outcome

  • Up to 108 samples and 270 tests/day processing capacity on myCROBE automated system
  • +4 more outcomes

Companies that use GeneProof

Customer profile

Named customers14 records

Segments8 records

Ideal customer profiles2 records

GeneProof technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration8 records

Feature6 records

GeneProof partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered minor and core.

  • DIANA BiotechnologiesminorGTM or Marketing Partner · 16 December 2025GeneProof entered a collaboration with DIANA Biotechnologies to distribute the RT-PCR Respiratory Panel 1, a multiplex test detecting Influenza A, Influenza B, RSV, and SARS-CoV-2 from a single sample. GeneProof acts as the distributor for this CE IVDD product, offering it through its global distribution network. The partnership leverages DIANA's expertise in innovative PCR products and GeneProof's established distribution channels.
  • Thermo Fisher ScientificcoreStrategic or Co-development Partner · 17 April 2023ALPCO-GeneProof and Thermo Fisher Scientific announced a strategic partnership in April 2023 to bring the TaqPath Menu | GeneProof PCR tests to market. This partnership leverages Thermo Fisher's global distribution reach for molecular diagnostics products, expanding GeneProof's market access significantly through Thermo Fisher's established commercial channels.
  • ALPCO (American Laboratory Products Company, Ltd.)coreStrategic or Co-development Partner · 1 January 2022In 2022, GeneProof merged with American Laboratory Products Company (ALPCO), a specialized in vitro diagnostics company based in Salem, USA. The merger created a global market leader in diagnostic products with broad capabilities including new immunoassay test kits, RT PCR testing products, and automated laboratory instrument solutions. ALPCO distributes GeneProof products in North America. GeneProof's parent company post-merger is NuvinkaDx.
  • BiosanminorChannel Partner/ Reseller/ Distributor · 1 January 2021GeneProof partnered with Biosan (European manufacturer of laboratory instruments) beginning in 2021 to offer complementary laboratory equipment including RTS-1C and RTS-8 bioreactors based on Reverse-Spin technology. Biosan focuses on innovations in molecular biology, biochemistry, immunology, and cell biology with over 30 years of R&D tradition.
  • AlpinaminorChannel Partner/ Reseller/ Distributor · 1 January 2021GeneProof partnered with Alpina (largest laminar flow cabinet manufacturer in Central Europe) beginning in 2021 to offer complementary laboratory equipment. Alpina manufactures over 20 models of laminar flow and biosafety cabinets certified to EN 12469, combining modern technology, highest quality materials, and precise manufacturing.
  • Google (Ads and Analytics)minorOthersGeneProof uses Google Analytics and Google AdWords for website analytics and digital advertising, with a Data Processing Amendment in place per GDPR requirements.
  • MailchimpminorOthersGeneProof uses Mailchimp for email marketing and commercial communications, with a Privacy Policy agreement in place per GDPR requirements.
  • FacebookminorOthersGeneProof maintains a Facebook company page and uses Facebook's data processing services with a Data Policy agreement in place per GDPR requirements.
  • LinkedInminorOthersGeneProof maintains a LinkedIn company page with a Data Processing Agreement in place per GDPR requirements.
  • ViaAureaminorOthersViaAurea provides web hosting and digital services for the GeneProof website (www.geneproof.com), with a Privacy Policy agreement in place per GDPR requirements.

Scale indicators9 records

Recent moves7 records

Expansion highlights5 records

GeneProof competitors and assessment

Company assessment

Direct peers

  • TIB Molbiol: TIB Molbiol (now owned by Roche) is one of the closest direct competitors to GeneProof in PCR-based molecular diagnostic kits for infectious diseases, including respiratory pathogens, HSV, CMV, and a similar ready-to-use master mix design philosophy. Competes head-to-head with GeneProof in the European clinical lab segment.
  • Seegene: Seegene is a Korean molecular diagnostics company specializing in multiplex PCR reagents for syndromic testing (respiratory, STI, gastrointestinal). Its high-multiplex technology and broad assay menu directly overlap with GeneProof's STI and respiratory infection product lines.
  • Fast Track Diagnostics (Siemens Healthineers): Fast Track Diagnostics, now part of Siemens Healthineers, develops real-time PCR kits for infectious disease and genetic testing with a portfolio and customer base closely aligned to GeneProof's. Both companies target mid-sized clinical laboratories with multiplex and single-plex kits.
  • ELITech Group: ELITech Group is a European molecular diagnostics company offering PCR kits, instruments, and extraction systems for infectious disease and genetic testing. Its product range and mid-market positioning directly overlap with GeneProof's portfolio and customer base.

Broad incumbents

  • DiaSorin: DiaSorin is a global diagnostics major with a molecular diagnostics franchise (including the Liaison MDX line acquired from Luminex). As a broader incumbent, it competes in the same IVD infectious disease and transplant testing space as GeneProof, but at much larger scale and with a wider product portfolio.
  • Cepheid (Danaher): Cepheid, owned by Danaher, sells the GeneXpert closed-cartridge molecular diagnostic system used widely in clinical labs and hospital point-of-care settings. It is a broader incumbent that competes with GeneProof's myCROBE sample-to-result system and PCR kits across infectious disease testing.
  • bioMérieux (BioFire): bioMérieux's BioFire FilmArray syndromic panels compete directly with GeneProof's respiratory and STI panels. As a global diagnostics major, bioMérieux offers fully integrated closed-system molecular diagnostics to the same clinical lab customers GeneProof serves.
  • QIAGEN: QIAGEN is a major life sciences and molecular diagnostics company whose PCR kits, extraction systems, and QIAstat-Dx platform overlap with GeneProof's product range. Its Rotor-Gene Q and broader instrument portfolio place it in adjacent competition across multiple of GeneProof's disease categories.
  • Hologic: Hologic's Panther molecular diagnostics system and Aptima assays serve the same clinical lab and hospital market as GeneProof, particularly in STI and women's health screening. As a broad incumbent with global reach, it competes for the same accounts.

Emerging players

  • Promega: Promega supplies nucleic acid extraction chemistries and molecular biology reagents used in clinical and research labs, with emerging clinical diagnostics offerings. While primarily a tools/reagents supplier, it overlaps with GeneProof's extraction and amplification reagent categories and competes for the same laboratory customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

GeneProof social profiles

Digital presence

GeneProof compliance and trust

Trust signal

Compliance4 records

GeneProof financial estimates

Financial estimate

Revenue estimate

Valuation estimate

GeneProof leadership team

Management profile

Number of profiles

Profiles10 records

GeneProof funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

GeneProof M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GeneProof

What does GeneProof do?

GeneProof develops, manufactures, and sells real-time PCR-based molecular in vitro diagnostic kits and instruments for clinical laboratories, hospitals, and public-health institutions. Its offerings span more than 75 CE IVD-certified PCR kits across seven disease categories (bloodborne infections, immunocompromised/transplant, sexually transmitted infections, neuroinfections, respiratory infections, antibiotic resistance, and thrombotic mutations), the myCROBE fully automated sample-to-result instrument, croBEE and croGENE real-time PCR systems, nucleic acid extraction systems, and consumables — sold through a global distributor network and direct sales teams in over 75 countries.

Is GeneProof a public or private company?

GeneProof is a private company. It is classified as corporate owned and is currently operating.

When was GeneProof founded?

GeneProof was founded in 2005. It employs 51 to 100 people.

Where is GeneProof based?

GeneProof is headquartered in Brno, Czechia, in the Europe region.

How does GeneProof make money?

Four revenue lines are on record. PCR Diagnostic Kits are the primary driver. The others are nucleic Acid Extraction Kits and Accessories, laboratory Instruments and distribution of Third-Party Products.

Who are GeneProof's main competitors?

Direct peers on record are TIB Molbiol, Seegene, Fast Track Diagnostics (Siemens Healthineers) and ELITech Group. Broad incumbents are DiaSorin, Cepheid (Danaher), bioMérieux (BioFire), QIAGEN and Hologic. Promega is listed as an emerging player.

Does GeneProof have an API?

No public API is recorded for GeneProof.

What industry is GeneProof in?

GeneProof's product category is Molecular In Vitro Diagnostics. Its primary akta.pro industry code is HLAHAAAD, Molecular Diagnostics (PCR/NAAT/NGS-based IVD), with a secondary code of HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireGeneProof Announces CMV IVDR Launch on the myCROBE™ FullyGeneProof announced its CMV MC PCR Kit is now available under the EU IVDR on the myCROBE platform. The assay meets Regulation (EU) 2017/746 and supports a line of IT PCR assays for transplant settings. The launch expands the myCROBE menu for clinical laboratories.openPR.comSaliva-based Screening Market CAGR 7.70% Trends with Thermo Fisher Scientific, Qiagen, Hologic, Takara Bio Inc, Arcis Biotechnology Limited, GeneProof, Abacus ALS, ChaiThe saliva-based screening market is projected to grow at a CAGR of 7.70% from 2025 to 2032, driven by non-invasive testing demand and technological advances. Key players include Thermo Fisher Scientific, Qiagen, and Hologic, with growth fueled by AI integration and point-of-care innovations.PR NewswireNuvinkaDx Announces Major Milestones for Portfolio Companies GeneProof and ALPCONuvinkaDx announced two milestones from its operating companies: GeneProof launched a line of STI PCR assays on its myCROBE platform in Europe, enabling simultaneous detection of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma hominis and Mycoplasma genitalium, with additional pathogens planned. Simultaneously, ALPCO obtained Health Canada licenses for gastrointestinal diagnostics including Calprotectin CLIA and Pancreatic Elastase CLIA assays on its flash chemiluminescent KleeYa platform. These milestones expand both companies' diagnostic offerings and geographic reach as part of NuvinkaDx's diversified diagnostics strategy.PR NewswireGeneProof Announces Expansion of its IVDR-Certified PCR PortfolioGeneProof announced the expansion of its IVDR-certified PCR portfolio with six new kits targeting sexually transmitted infections, including multiplex tests for Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma species. The Czech Republic-based molecular diagnostics company currently has 27 IVDR-cleared products, with 16 Notified Body certified in class C and B, and is working toward having its entire portfolio of approximately 80 products IVDR compliant by 2027. GeneProof, which merged with ALPCO in 2022, was among the first European companies to obtain EU certification under the new IVDR regulation that took effect in January 2023.PR.comThermo Fisher Partners with ALPCO-GeneProof to Broaden Their CE-IVD Molecular Assay Portfolio - PR.comThermo Fisher and ALPCO-GeneProof announced a partnership to bring 37 CE-IVD molecular diagnostic assays to market via TaqPath Menu | GeneProof PCR kits. The portfolio, built on a one-workflow technology, will be released in phases starting with a panel for bloodborne and sexually transmitted infections, with additional panels for respiratory, transplant, and other infections following. The launch will occur at ECCMID 2023 in Copenhagen.PR.comAmerican Laboratory Products Company Merges with GeneProof - PR.comAmerican Laboratory Products Company (ALPCO) announced a merger with GeneProof, a Czech molecular diagnostics firm. The combined company, majority owned by Ampersand Capital Partners, will offer immunoassay and PCR testing products. GeneProof's founders will remain as significant shareholders.PR NewswireAmerican Laboratory Products Company Merges with GeneProofAmerican Laboratory Products Company, Ltd. (ALPCO) announced a merger with GeneProof a.s., creating a global leader in the diagnostic products market on April 21, 2022. The merger combines ALPCO's immunodiagnostic capabilities with GeneProof's molecular diagnostics expertise and is expected to facilitate both companies' entry into new markets. This strategic alliance aims to enhance their technological capabilities and expand their geographic presence.AlpcoAmerican Laboratory Products Company Merges with GeneProofAmerican Laboratory Products Company (ALPCO) announced a merger with GeneProof, a molecular diagnostics firm based in the Czech Republic, to create a global market leader in diagnostic products. The combination integrates ALPCO's immunoassay capabilities with GeneProof's real-time PCR technologies and automated instrumentation, backed by majority owner Ampersand Capital Partners. This strategic alliance aims to expand GeneProof's presence into the US market while growing ALPCO's footprint in Europe and globally.